Skip to content

A clinical research study for Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T)

A clinical research study to evaluating the safety and effectiveness of an
investigational drug (Mitapivat) in study participants with Transfusion-Dependent
Alpha- or Beta-Thalassemia (ENERGIZE-T)

null

Participation Requirements

  • Sex:

    Male, Female, Intersex

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:
You may be eligible to participate in this trial if you are:
- ≥18 years of age
- have been diagnosed with thalassemia
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion Criteria:
You may not be eligible to participate in this trial if you:
- have received gene therapy or bone marrow or stem cell transplantation
- female who is breast feeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.

Study Location

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contact Study Team

Study Sponsored By
University of Calgary
Participants Required
More Information
Study ID: REB21-0766